Who
Henry Ji
Exec Chair, CEO and President
Company insider
Files Form 4 as: Exec Chair, CEO and President, Scilex Holding; President and CEO, Sorrento Therapeutics.
In numbers
- Trades disclosed
- 102
- Buys
- 26
- Sells
- 0
- Bought
- $2.9M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 21 Sep 2009
- Last trade
- 17 Apr 2026
- Last filed
- 20 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Apr 2026filed 20 Apr 2026 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code S | $100K650,000 at $0.1538 | filing |
| 17 Apr 2026filed 20 Apr 2026 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code S | $98K650,000 at $0.15 | filing |
| 16 Apr 2026filed 20 Apr 2026 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code P | $500K3,250,000 at $0.1538 | filing |
| 16 Apr 2026filed 20 Apr 2026 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code P | $488K3,250,000 at $0.15 | filing |
| 8 Oct 2025filed 9 Oct 2025 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 31 Oct 2024filed 31 Oct 2024 | SCLX Scilex HoldingPharmaceuticals | SEC FORM 4 Bought | $8,3558,888 at $0.94 | filing |
| 17 Oct 2024filed 18 Oct 2024 | SCLX Scilex HoldingPharmaceuticals | SEC FORM 4 Bought | $9,70010,000 at $0.97 | filing |
| 18 Jun 2024filed 18 Jun 2024 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —6,000 at $0.00 | filing |
| 18 Jun 2024filed 18 Jun 2024 | SCLX Scilex HoldingPharmaceuticals | SEC FORM 4 Code M | $8,4606,000 at $1.41 | filing |
| 17 May 2024filed 17 May 2024 | SCLX Scilex HoldingPharmaceuticals | SEC FORM 4 Bought | $44K50,000 at $0.88 | filing |
| 4 Oct 2023filed 5 Oct 2023 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 17 Mar 2023filed 20 Mar 2023 | SCLX Scilex HoldingPharmaceuticals | SEC FORM 4 Code J | $23K2,730 at $8.60 | filing |
| 17 Mar 2023filed 20 Mar 2023 | Sorrento Therapeuticsoption or derivative | SEC FORM 4 Code D | —195 at $0.00 | filing |
| 17 Mar 2023filed 20 Mar 2023 | Sorrento Therapeutics | SEC FORM 4 Code X | $16K19,500 at $0.80 | filing |
| 17 Jan 2023filed 17 Jan 2023 | SCLX Scilex Holdingoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —9,000,000 at $0.00 | filing |
| 21 Dec 2022filed 23 Dec 2022 | Sorrento Therapeuticsoption or derivative | SEC FORM 4 Code X | —3 at $0.00 | filing |
| 21 Dec 2022filed 23 Dec 2022 | Sorrento Therapeutics | SEC FORM 4 Code X | $1,650300 at $5.50 | filing |
| 15 Dec 2022filed 16 Dec 2022 | Sorrento Therapeutics | SEC FORM 4 Code A | —1,500,000 at $0.00 | filing |
| 2 Dec 2022filed 23 Dec 2022 | Sorrento Therapeuticsoption or derivative | SEC FORM 4 Code X | —2 at $0.00 | filing |
| 2 Dec 2022filed 23 Dec 2022 | Sorrento Therapeutics | SEC FORM 4 Code X | $1,100200 at $5.50 | filing |
News
David Seymour in Hastings: Act leader says Greens 'certainly are people' after Paul Henry jibenzherald.co.nz · 7 Sep 2026Head-To-Head Contrast: Scilex (NASDAQ:SCLX) versus Eli Lilly and Company (NYSE:LLY)SCLX · themarketsdaily.com · 9 Oct 2026
1 headline in the last 90 days name Henry Ji; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.